期刊
HELICOBACTER
卷 22, 期 -, 页码 -出版社
WILEY
DOI: 10.1111/hel.12412
关键词
gastric cancer stem cells; immune checkpoint inhibition; marker; microRNAs; molecular classification
资金
- Fundacao para a Ciencia e a Tecnologia through Programa Operacional Capital Humano [PD/BD/114014/2015, PD/0016/2012]
- Universidad de Costa Rica
- Ministerio de Ciencia, Tecnologia y Telecomunicaciones
- ERDF funds [NORTE-01-0145-FEDER-000029]
- Fundação para a Ciência e a Tecnologia [PD/BD/114014/2015] Funding Source: FCT
Gastric cancer is one of the most incident and deadliest malignancies in the world. Gastric cancer is a heterogeneous disease and the end point of a long and multistep process, which results from the stepwise accumulation of numerous (epi) genetic alterations, leading to dysregulation of oncogenic and tumor suppressor pathways. Gastric cancer stem cells have emerged as fundamental players in cancer development and as contributors to gastric cancer heterogeneity. For this special issue, we will report last year's update on the gastric cancer molecular classification, and in particular address the gastric cancer groups who could benefit from immune checkpoint therapy. We will also review the latest advances on gastric cancer stem cells, their properties as gastric cancer markers and therapeutic targets, and associated signaling pathways. The understanding of the molecular basis underlying gastric cancer heterogeneity and of the role played by gastric cancer stem cells in cancer development and heterogeneity is of major significance, not only for identifying novel targets for cancer prevention and treatment, but also for clinical management and patient stratification for targeted therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据